Φορτώνει......
Cisplatin Activates the Growth Inhibitory Signaling Pathways by Enhancing the Production of Reactive Oxygen Species in Non-small Cell Lung Cancer Carrying an EGFR Exon 19 Deletion
Background/Aim: Cisplatin is a potent anticancer drug for treating several types of cancer, including non-small-cell lung cancer (NSCLC). In this study, we investigated the cytotoxicity and mechanism of action of cisplatin in the human NSCLC cell line PC9. Materials and Methods: PC9 cells were treat...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Genomics Proteomics |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
International Institute of Anticancer Research
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8240041/ https://ncbi.nlm.nih.gov/pubmed/33994369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20273 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|